IL6 and age-related macular degeneration: Additionally, a combination treatment of PU-91 plus quercetin induced upregulation of key factors like SOD2, IL-6, and BAX, suggesting potential benefits in terms of cellular metabolism and mitochondrial biogenesis in AMD cybrids, albeit leading to a senescent phenotype [456].